Form 4: Xylem Inc. Executive McShane Reports Stock Transactions
SEC Form 4
Geri-Michelle McShane, VP, Controller & CAO of Xylem Inc., reports acquisition and disposal of company stock and stock options related to vesting of performance-based stock units and restricted stock units.
Summary
- Geri-Michelle McShane, VP, Controller & CAO of Xylem Inc., filed a Form 4 on March 5, 2024, reporting transactions in Xylem Inc. stock.
- On March 1, 2024, McShane acquired 814 shares of common stock upon vesting of performance-based stock units at a price of $127.94.
- An additional 501 shares were acquired upon vesting of performance-based restricted stock units at the same price.
- 516 shares were withheld to cover tax liabilities related to the vesting of performance-based stock units.
- 243 shares were withheld to cover tax liabilities related to the vesting of restricted stock units.
- McShane was also awarded 557 restricted stock units that vest in one third increments on March 1, 2025, March 1, 2026 and March 1, 2027.
- McShane was also awarded 1,884 non-qualified stock options that vest in one-third increments on March 1, 2025, March 1, 2026 and March 1, 2027.
- Following these transactions, McShane directly owns 4,048 shares of common stock and 1,884 stock options.
Sentiment
Score: 6
Explanation: The sentiment is neutral as the document primarily reports routine stock transactions related to executive compensation. The vesting of performance-based units suggests positive performance, but the overall impact is balanced.
Positives
- The vesting of performance-based stock units indicates achievement of performance criteria related to ROIC and Total Shareholder Return.
- The award of restricted stock units and stock options aligns McShane's interests with the long-term performance of the company.
Future Outlook
The restricted stock units and stock options are scheduled to vest in one-third increments on March 1, 2025, March 1, 2026, and March 1, 2027, indicating future equity-based compensation.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company executives.
Comparison to Industry Standards
- Stock-based compensation is a common practice among publicly traded companies to align management's interests with shareholders.
- Vesting schedules of three years are typical for restricted stock units and stock options.
- Companies like Danaher, Roper Technologies, and Advanced Drainage Systems also utilize similar equity compensation plans for their executives.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect routine executive compensation.
- Employees may be indirectly affected by the vesting of performance-based units, which are tied to company performance.
Key Dates
| Date | Description |
|---|---|
| 2016-02-24 | Date of the Amended and Restated Xylem Omnibus Incentive Plan. |
| 2021-03-01 | Grant date of performance-based stock units and restricted stock units. |
| 2022-03-01 | Grant date of restricted stock units. |
| 2023-03-01 | Grant date of restricted stock units. |
| 2023-11-15 | Date of Power of Attorney signed by Geri McShane. |
| 2024-03-01 | Date of stock transactions and vesting of stock units and options. |
| 2024-03-05 | Date of Form 4 filing. |
| 2025-03-01 | First vesting date for restricted stock units and stock options. |
| 2026-03-01 | Second vesting date for restricted stock units and stock options. |
| 2027-03-01 | Third vesting date for restricted stock units and stock options. |
| 2034-03-01 | Expiration date for stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.